The phosphoinositide-binding protein TRAF4 modulates tight junction stability and migration of cancer cells

Adrien Rousseau1, Léa P Wilhelm2, Catherine Tomasetto2

  • 1Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC); Functional Genomics and Cancer Department ; Illkirch, France ; Institut National de la Santé et de la Recherche Médicale (INSERM) ; Illkirch, France ; Centre National de la Recherche Scientifique (CNRS) ; Illkirch, France ; Université de Strasbourg ; Illkirch, France ; Present address: MRC Laboratory of Molecular Biology ; Cambridge, UK.

Tissue Barriers
|January 23, 2015
PubMed

Insights

Tumor necrosis factor-associated factor 4 (TRAF4) protein overexpression in carcinomas impedes cell junctions and promotes cancer progression. TRAF4

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4) is overexpressed in carcinomas.
  • TRAF4 localizes to tight junctions (TJs) in normal epithelial cells.
  • TRAF4 impedes TJ formation/stability and promotes cell migration, key aspects of cancer progression.

Purpose of the Study:

  • To investigate the role of TRAF4 in cancer progression.
  • To elucidate the mechanism of TRAF4 recruitment to TJs.
  • To explore TRAF4 as a potential therapeutic target.

Main Methods:

  • Investigated TRAF4's function in TJ formation, stability, and cell migration.
  • Examined TRAF4's contribution to TGF-β-induced epithelial-mesenchymal transition (EMT) and metastasis.
  • Studied TRAF4 recruitment to TJs via lipid-binding and its interaction with phosphoinositides (PIPs).

Main Results:

  • TRAF4 overexpression impedes TJ formation/stability and enhances cell migration.
  • TRAF4 promotes TGF-β-induced EMT, metastasis, and p53 destabilization.
  • TRAF4 is recruited to TJs through lipid-binding, interacting with 3 PIP molecules via its trimeric TRAF domain.

Conclusions:

  • TRAF4 plays a significant role in cancer progression by disrupting TJs and promoting cell migration and metastasis.
  • TRAF4's lipid-binding ability is crucial for its function and represents a novel link between lipid metabolism and cancer.
  • TRAF4 is a potential therapeutic target for cancer treatment, and its lipid-binding function may be conserved across the TRAF protein family.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.9K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
11.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Tight Junctions01:29

Tight Junctions

Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K